However, elevated IDO expression has been associated with an improved survival of gastric carcinomas [49], basal-like breast cancer [50], cervical cancer [51], renal cell carcinomas [52], and esophageal adenocarcinomas [17]. The gene discussed is IDO1; the disease is breast cancer.